Aryl hydrocarbon receptor activation ameliorates experimental colitis by modulating the tolerogenic dendritic and regulatory T cell formation

被引:0
作者
Xiufang Cui
Ziping Ye
Di Wang
Yan Yang
ChunHua Jiao
Jingjing Ma
Nana Tang
Hongjie Zhang
机构
[1] Nanjing First Hospital,Department of Gastroenterology
[2] Nanjing Medical University,Department of Gastroenterology
[3] First Affiliated Hospital of Nanjing Medical University,Department of Gastroenterology
[4] Sir Run Run Hospital,undefined
[5] Nanjing Medical University,undefined
来源
Cell & Bioscience | / 12卷
关键词
Aryl hydrocarbon receptor; Crohn’s disease; Dendritic cells; Intestinal immune tolerance; Treg cells;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 120 条
[1]  
Guan Q(2019)A comprehensive review and update on the pathogenesis of inflammatory bowel disease J Immunol Res 148 32-46
[2]  
Afzali B(2007)The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease Clin Exp Immunol 33 e336-10
[3]  
Lombardi G(2018)Mucosal immunity related to FOXP3(+) regulatory T Cells, Th17 cells and cytokines in pediatric inflammatory bowel disease J Korean Med Sci 13 3-2329
[4]  
Lechler RI(2018)Innate and adaptive immunity in inflammatory bowel disease Autoimmun Rev 20 2321-2450
[5]  
Cho J(2014)Comprehensive intestinal T helper cell profiling reveals specific accumulation of IFN-gamma+IL-17+coproducing CD4+ T cells in active inflammatory bowel disease Inflamm Bowel Dis 119 2441-247
[6]  
Kim S(2009)Dendritic cells in intestinal homeostasis and disease J Clin Invest 198 235-726
[7]  
Yang DH(2009)Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells J Exp Med 1 14-3617
[8]  
Geremia A(2012)Human tolerogenic DC-10: perspectives for clinical applications Transplant Res 76 719-744
[9]  
Biancheri P(2004)Heme oxygenase 1 expression induced by IL-10 requires STAT-3 and phosphoinositol-3 kinase and is inhibited by lipopolysaccharide J Leukoc Biol 197 3607-109
[10]  
Allan P(2004)IL-10-modulated human dendritic cells for clinical use: identification of a stable and migratory subset with improved tolerogenic activity J Immunol 204 733-3693